Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera.
The effects of somatostatin on diarrhea and on small intestinal flow of water and electrolytes (slow-marker perfusion technique) in a patient with pancreatic cholera are reported. Continuous intravenous infusion of somatostatin (8 micrograms/kg/hr) suppressed the diarrhea, but a rebound was observed after somatostatin. Infusion of somatostatin at the same dosage decreased the ileal fluid flow rate to within control values. This effect was mainly due to a sharp reduction in the rate fluid entered the jejunum, but was also due to a suppression of the abnormal water and electrolyte secretion in the proximal jejunum. Secretion in the rest of the small bowel remained unchanged. Somatostatin did not noticeably alter the high preinfusion plasma level of prostaglandin E1, but decreased the initially high plasma concentration of vasoactive intestinal peptide to normal values. These results suggest that long-acting somatostatin analogs could be of value in the symptomatic treatment of diarrhea in pancreatic cholera.
D007516:Adenoma, Islet Cell / Q000188:drug therapy*; D000328:Adult; D006801:Humans; D007263:Infusions, Parenteral; D007421:Intestine, Small / Q000187:drug effects / Q000378:metabolism; D008297:Male; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D011458:Prostaglandins E / Q000097:blood; D013004:Somatostatin / Q000097:blood / Q000627:therapeutic use*; D014660:Vasoactive Intestinal Peptide / Q000097:blood; D003969:Vipoma / Q000188:drug therapy* / Q000378:metabolism; D014882:Water-Electrolyte Balance / Q000187:drug effects*
D011458:Prostaglandins E; D014660:Vasoactive Intestinal Peptide; D013004:Somatostatin